New order valued at 15.2 MSEK smashes previous company record

Redsense Medical has secured a new order valued at 15.2 MSEK from one of the company’s US distributors.

“An order of this magnitude is of course extremely exciting and marks not only a special milestone as the largest in the company’s history, but also signifies a turning point in re-gaining momentum in the US market” says Pontus Nobréus CEO of Redsense Medical AB.

“The order will be delivered in partial which means an extremely strong finish to 2022 and a solid foundation for an excellent start of 2023. We are working with our distribution and supply chain partners on establishing a delivery plan and an inventory level framework moving forward. We have a clear focus on providing patient safety and this order can help us double down on our activities” continues Pontus Nobréus.

This information is information that Redsense Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out below, on December 02, 2022.